As part of the international consortium of the AutoCRAT (Automated Cellular Robot-Assisted Technologies, grant no. 874671) project, Panaxea is evaluating the cost-effectiveness of an innovative robot-assisted platform to manufacture stem cells that can be used to treat osteoarthritis (OA) and possibly, in the future, also other diseases. Osteoarthritis is a disease affecting millions of people […]